Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer.

Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer.

Item
http://www.wikidata.org/entity/Q43899648
Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population.Cost effectiveness of treatment with new agents in advanced non-small-cell lung cancer: a systematic review.Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based AnalysisTreatment paradigms for patients with metastatic non-small-cell lung cancer: first-, second-, and third-line.Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration.A systematic review of economic evaluations in second and later lines of therapy for the treatment of non-small cell lung cancer.Gefitinib: a consideration of cost.Cost effectiveness of dabrafenib as a first-line treatment in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma in Canada.
P2860

Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer.

Item
http://www.wikidata.org/entity/Q43899648
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Economic analysis of the TAX 3 ...... ed non-small-cell lung cancer.
@en
Economic analysis of the TAX 3 ...... ed non-small-cell lung cancer.
@nl
type
label
Economic analysis of the TAX 3 ...... ed non-small-cell lung cancer.
@en
Economic analysis of the TAX 3 ...... ed non-small-cell lung cancer.
@nl
prefLabel
Economic analysis of the TAX 3 ...... ed non-small-cell lung cancer.
@en
Economic analysis of the TAX 3 ...... ed non-small-cell lung cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Economic analysis of the TAX 3 ...... ed non-small-cell lung cancer.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698